Journal of Virology · 2006 · 101 citations · 44 references
Life SciencesMolecular BiologyOncologyMolecular OncologyMolecular VirologyVirologyOncogenic Signaling PathwaysOncogenic VirusesViral OncogenesViral OncogenesisViral ReplicationDominant Negative EffectsDominant Negative MutationsMek InhibitionMek SignalingOncogenic Viral MechanismsOncogenic Virus BiologyViral Replication ControlViral Replication Inhibition
Herpes simplex virus mutants lacking the gamma(1)34.5 gene are not destructive to normal tissues but are potent cytolytic agents in human tumor cells in which the activation of double-stranded RNA-dependent protein kinase (PKR) is suppressed. Thus, replication of a Deltagamma(1)34.5 mutant (R3616) in 12 genetically defined cancer cell lines correlates with suppression of PKR but not with the genotype of RAS. Extensive analyses of two cell lines transduced with either dominant negative MEK (dnMEK) or constitutively active MEK (caMEK) indicated that in R3616 mutant-infected cells dnMEK enabled PKR activation and decreased virus yields, whereas caMEK suppressed PKR and enabled better viral replication and cell destruction in transduced cells in vitro or in mouse xenografts. The results indicate that activated MEK mediates the suppression of PKR and that the status of MEK predicts the ability of Deltagamma(1)34.5 mutant viruses to replicate in and destroy tumor cells.
44
Mutations of the BRAF gene in human cancer
Helen Davies, Graham R. Bignell, Charles Cox et al. · Nature · 2002 · 10.7K citations
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Zhengui Xia, Martin Dickens, Joël Raingeaud et al. · Science · 1995 · 5.3K citations
Creation of human tumour cells with defined genetic elements
William C. Hahn, Christopher M. Counter, Ante S. Lundberg et al. · Nature · 1999 · 2.3K citations
Medicine, Cancer Biology, Genetics +13